Familial Mediterranean fever (FMF) is the prototype of auto-inflammatory disorders and is
ethnically restricted to people living in the Mediterranean basin and Middle-East. Pyrin, the …

Familial Mediterranean fever (FMF) is the most common hereditary autoinflammatory
syndrome. FMF is caused by mutations in the MEFV gene which encodes the pyrin protein …

Familial Mediterranean fever (FMF) is a hereditary auto-inflammatory disease, characterised
by recurrent episodes of fever and serositis. Since 1972, colchicine has been the drug of …

OBJECTIVE: To identify any adverse effects of colchicine in a pediatric patients with familial
Mediterranean fever (FMF). STUDY DESIGN: Clinical presentation, Mediterranean fever …

Pharmacological and Clinical Basis of Treatment of Familial Mediterranean Fever (FMF) with
Colchicine or Analogues: An Update Page 1 Current Drug Targets - Inflammation & Allergy …

Colchicine is the treatment of choice in familial Mediterranean fever (FMF) for the prevention
of both attacks and secondary amyloidosis. The overall nonresponder rate is about 5–10 …

Familial Mediterranean fever (FMF) is the most common autoinflammatory disease
worldwide. Approximately 5–10% of patients are unresponsive to colchicine. Aim of this …

Familial Mediterranean Fever (FMF) is a rare autosomal recessive autoinflammatory
disorder involving the innate immunity and affecting almost exclusively populations with …

Familial Mediterranean fever (FMF) is the most common monogenic autoinflammatory
disease and is usually diagnosed in childhood, especially in the first decade of life …

Abstract Background Familial Mediterranean fever (FMF) is an autosomal recessive disease
characterized by self-limiting recurrent attacks of fever and serosal inflammation, leading to …